<html>
<head>PUBMED IDs for SCGB2A2</head>
<body bgcolor='#C5F0F2'><h1>SCGB2A2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/14515009/'>Relationship between mammaglobin expression and estrogen receptor status in breast tumors.</a> September 30  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/15451460/'>The human SCGB2A2 (mammaglobin-1) promoter/enhancer in a helper-dependent adenovirus vector directs high levels of transgene expression in mammary carcinoma cells but not in normal nonmammary cells.</a> September 29  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/16603086/'>Expression analysis of mammaglobin A (SCGB2A2) and lipophilin B (SCGB1D2) in more than 300 human tumors and matching normal tissues reveals their co-expression in gynecologic malignancies.</a> April 11  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16773180/'>Gene expression profiling of paired ovarian tumors obtained prior to and following adjuvant chemotherapy: molecular signatures of chemoresistant tumors.</a> June 15  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/21796834/'>[Possible application of pharmacogenomics to warfarin therapy].</a> August 6  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22118813/'>ABCB1/MDR1 contributes to the anticancer drug-resistant phenotype of IPH-926 human lobular breast cancer cells.</a> February 14  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/24603286/'>Differential expression of secretoglobins in normal ovary and in ovarian carcinoma--overexpression of mammaglobin-1 is linked to tumor progression.</a> May 28  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24948454/'>Fabrication and functionalization of PCB gold electrodes suitable for DNA-based electrochemical sensing.</a> February 3  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25676557/'>Keratoacanthoma and squamous cell carcinoma are distinct from a molecular perspective.</a> March 26  2015<br></body></html>
